Relugolix is a prescription medication used to treat adults with advanced prostate cancer. It is used in combination with other medications to reduce testosterone levels in the body and slow the growth of the cancer. It is taken as a tablet once a day. Common side effects include hot flashes, joint pain, and fatigue.
Relugolix is a prescription medication used to treat adult men with advanced prostate cancer. Here's a breakdown of its mechanism of action and how it helps with this condition:
How it Works:
- Relugolix belongs to a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists [1, 2]. These drugs work by blocking the action of a hormone called gonadotropin-releasing hormone (GnRH) [1].
- GnRH plays a crucial role in stimulating the production of testosterone by the testicles. Testosterone is a male sex hormone that fuels the growth of some prostate cancers [1, 2].
- By blocking GnRH receptors, Relugolix essentially reduces testosterone production. This helps to slow down the growth and spread of prostate cancer cells that depend on testosterone for survival [1, 2].
Benefits of Relugolix:
- In patients with advanced prostate cancer, Relugolix can help to:
- Delay disease progression [1, 2].
- Improve overall outcomes and potentially extend time before other treatments are needed [2].
How it's Administered:
- Relugolix comes as a tablet taken by mouth, usually once daily with or without food [1, 2].
Important Considerations:
- Relugolix is not suitable for everyone. Your doctor will assess your individual situation and medical history before prescribing it [2].
- Potential side effects include hot flashes, fatigue, headache, diarrhea, and breast enlargement [2].
- Regular monitoring by your doctor is necessary while taking Relugolix, including blood tests to assess testosterone levels and monitor for potential side effects [2].
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L02 Endocrine therapy
L02B - Hormone antagonists and related agents
L02BX Other hormone antagonists and related agents
ATC Code
Anatomical Therapeutic Chemical Classification
H - Systemic hormonal preparations, excluding sex hormones and insulins
H01 Pituitary and hypothalamic hormones and analogues
H01C - Hypothalamic hormones
H01CC Anti-gonadotropin-releasing hormones
ATC Code
External Links
Relugolix